Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Pharmtech & Ingredient...Pharmtech & Ingredients
Not Confirmed
Not Confirmed
19-22 November, 2024
Rescon USA SummitRescon USA Summit
Not Confirmed
Not Confirmed
21-22 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Pharmtech & Ingredient...Pharmtech & Ingredients
Industry Trade Show
Not Confirmed
19-22 November, 2024
Rescon USA SummitRescon USA Summit
Industry Trade Show
Not Confirmed
21-22 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
18 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/anixa-biosciences-initiates-dosing-in-third-cohort-in-its-ovarian-cancer-car-t-clinical-trial-302307993.html
08 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/anixa-biosciences-and-cleveland-clinic-present-new-updated-positive-data-from-phase-1-study-of-breast-cancer-vaccine-at-the-39th-society-for-immunotherapy-of-cancer-sitc-annual-meeting-302299962.html
28 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/anixa-biosciences-and-cleveland-clinic-to-present-additional-data-from-phase-1-study-of-breast-cancer-vaccine-at-the-39th-society-for-immunotherapy-of-cancer-sitc-annual-meeting-302288176.html
15 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/anixa-biosciences-announces-second-dose-administered-to-patient-in-ovarian-cancer-car-t-clinical-trial-302276442.html
24 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/anixa-biosciences-unveils-phase-2-study-plan-for-breast-cancer-vaccine-302256451.html
24 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/anixa-biosciences-treats-sixth-patient-in-its-ovarian-cancer-car-t-clinical-trial-302179663.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?